Latest Capital Raise News

Australian Bond Exchange Holdings has completed a $982,071 private placement, attracting new international and domestic investors to support its growth strategy.

Empire Resources has successfully raised nearly $2.9 million through the first tranche of its planned $5 million placement, with a second tranche pending shareholder approval in March.

Jayride Group Limited reports a narrower quarterly loss amid revenue challenges, secures $200,000 through convertible notes, and inks a new SaaS agreement with Thailand’s Drivemate to expand its mobility platform.

BPH Energy Ltd reported a half-year net loss of $925,691, weighed down by investment write-downs and associate losses, while raising $1.2 million to fund exploration and development. The company’s future hinges on a Federal Court review of a critical offshore permit held by investee Advent Energy.

Santana Minerals has raised A$130 million through a two-tranche placement and plans a share purchase plan to accelerate development of its Bendigo Ophir Gold Project. The equity raise aims to fund early works, exploration, and equipment procurement ahead of final resource consents.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

Kali Metals Limited has successfully raised approximately A$7 million through a Tranche 1 Placement, issuing over 38 million new shares at 18 cents each. This capital injection marks a significant step in the company’s funding strategy.

Elementos Limited has raised $29.5 million through a strategic placement to L1 Capital, strengthening its financial position as it pushes forward with key tin projects in Spain and Tasmania.

Whitefield Income Limited reported a robust half-year profit surge and a significant capital raise, maintaining steady dividends amid a cautiously optimistic economic outlook.

Select Harvests Limited has reported a strong FY2025 financial performance with a net profit after tax of $31.8 million and a significant reduction in net debt. The company plans to resume dividend payments in 2026 amid favourable almond market conditions.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.